Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current drug therapy for multiple myeloma.

Y W Huang1, A Hamilton, O J Arnuk

  • 1Department of Medicine, Staten Island University Hospital, New York 10305, USA. ywhuang@aol.com

Drugs
|May 11, 1999
PubMed
Summary

Advances in multiple myeloma treatment show new chemotherapy regimens and stem cell transplantation significantly improve survival rates. Emerging immunotherapies and targeted agents offer further promise for managing this complex blood cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operation and performance of the ATLAS Tile Calorimeter in Run 1.

The European physical journal. C, Particles and fields·2019
Same author

Search for electroweak production of supersymmetric particles in final states with two or three leptons at <math> </math> with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of the azimuthal anisotropy of charged particles produced in <math> </math> = 5.02 TeV Pb+Pb collisions with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Search for Higgs boson pair production in the <math></math> channel using <math></math> collision data recorded at <math></math> <math></math> TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Observation of Centrality-Dependent Acoplanarity for Muon Pairs Produced via Two-Photon Scattering in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2018
Same author

Combination of the Searches for Pair-Produced Vectorlike Partners of the Third-Generation Quarks at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2018

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Multiple myeloma treatment has long relied on melphalan and prednisone (MP) chemotherapy.
  • MP is no longer the gold standard, especially for patients undergoing intensive therapies or those with refractory disease.

Purpose of the Study:

  • To review recent advances in the molecular pathogenesis and management of multiple myeloma.
  • To highlight novel therapeutic strategies and their impact on patient outcomes.

Main Methods:

  • Review of current literature on multiple myeloma treatment modalities.
  • Analysis of data on chemotherapy regimens, stem cell transplantation, and emerging therapies.

Main Results:

  • New combination chemotherapy regimens demonstrate improved response rates and survival compared to standard MP.

Related Experiment Videos

  • Early high-dose chemotherapy with autologous stem cell support significantly increases complete remission and survival.
  • Allogeneic transplantation is beneficial for select patients with poor prognoses.
  • P-glycoprotein inhibitors show potential in reversing multidrug resistance.
  • Immunotherapy and novel supportive care agents are improving quality of life.

    • Conclusions:

    • Modern treatment approaches, including novel chemotherapy, stem cell transplantation, and targeted therapies, have significantly advanced multiple myeloma management.
    • Further research into immunotherapeutic and supportive care strategies holds promise for improved patient outcomes and quality of life.